Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNA-125a-Loaded Polymeric Nanoparticles Alleviate Systemic Lupus Erythematosus by Restoring Effector/Regulatory T Cells Balance
Jiali Zhang, Chuanrong Chen, Hao Fu, et al.
ACS Nano (2020) Vol. 14, Iss. 4, pp. 4414-4429
Closed Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Non-viral vectors for RNA delivery
Yi Yan, Xiaoyu Liu, Lu An, et al.
Journal of Controlled Release (2022) Vol. 342, pp. 241-279
Open Access | Times Cited: 226
Spleen-selective co-delivery of mRNA and TLR4 agonist-loaded LNPs for synergistic immunostimulation and Th1 immune responses
Longze Pan, Lijing Zhang, Wenjing Deng, et al.
Journal of Controlled Release (2023) Vol. 357, pp. 133-148
Closed Access | Times Cited: 47
Delivery of miRNAs through Metal–Organic Framework Nanoparticles for Assisting Neural Stem Cell Therapy for Ischemic Stroke
Hongru Yang, Min Ho Han, Jian Li, et al.
ACS Nano (2022) Vol. 16, Iss. 9, pp. 14503-14516
Closed Access | Times Cited: 54
Molecular Mechanisms of Immunosenescene and Inflammaging: Relevance to the Immunopathogenesis and Treatment of Multiple Sclerosis
Océane Perdaens, Vincent Van Pesch
Frontiers in Neurology (2022) Vol. 12
Open Access | Times Cited: 41
PLGA Particles in Immunotherapy
Dennis J. Horvath, Michael Basler
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 615-615
Open Access | Times Cited: 33
Nanomedicine for T‐Cell Mediated Immunotherapy
Fangzhou Li, Jiang Ouyang, Zuqin Chen, et al.
Advanced Materials (2023) Vol. 36, Iss. 22
Closed Access | Times Cited: 28
Exploring precision treatments in immune‐mediated inflammatory diseases: Harnessing the infinite potential of nucleic acid delivery
Lingxiao Xu, Z. Shao, Xia Fang, et al.
Exploration (2024)
Open Access | Times Cited: 15
Lymphoid organ-targeted nanomaterials for immunomodulation of cancer, inflammation, and beyond
Jessica C. Hsu, Peng Liu, Yangmeihui Song, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 15, pp. 7657-7680
Closed Access | Times Cited: 12
Nanorepair medicine for treatment of organ injury
Han Wang, Jessica C Hsu, Wenyu Song, et al.
National Science Review (2024) Vol. 11, Iss. 9
Open Access | Times Cited: 11
Nanomaterials in Immunology: Bridging Innovative Approaches in Immune Modulation, Diagnostics, and Therapy
George-Alexandru Croitoru, Diana-Cristina Pîrvulescu, Adelina-Gabriela Niculescu, et al.
Journal of Functional Biomaterials (2024) Vol. 15, Iss. 8, pp. 225-225
Open Access | Times Cited: 9
Nanostructured Drug Delivery Systems in Immunotherapy: An Updated Overview of Nanotechnology-Based Therapeutic Innovations
George-Alexandru Croitoru, Adelina-Gabriela Niculescu, Dragoș Epistatu, et al.
Applied Sciences (2024) Vol. 14, Iss. 19, pp. 8948-8948
Open Access | Times Cited: 9
T Cell-Targeting Nanotherapies for Atherosclerosis
Karla Lambaren, Noah Trac, Daniel J. Fehrenbach, et al.
Bioconjugate Chemistry (2025)
Closed Access | Times Cited: 1
Epigenetics in autoimmune diseases: Unraveling the hidden regulators of immune dysregulation
Giacomo Bagni, Edoardo Biancalana, Emanuele Chiara, et al.
Autoimmunity Reviews (2025) Vol. 24, Iss. 6, pp. 103784-103784
Open Access | Times Cited: 1
Immune and Inflammation in Acute Coronary Syndrome: Molecular Mechanisms and Therapeutic Implications
Haiming Wang, Zifan Liu, Junjie Shao, et al.
Journal of Immunology Research (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 65
Asynchronous blockade of PD-L1 and CD155 by polymeric nanoparticles inhibits triple-negative breast cancer progression and metastasis
Chuanrong Chen, Qianqian Guo, Hao Fu, et al.
Biomaterials (2021) Vol. 275, pp. 120988-120988
Closed Access | Times Cited: 55
Immunosuppressive microvesicles-mimetic derived from tolerant dendritic cells to target T-lymphocytes for inflammation diseases therapy
Minghao Lin, Siyun Lei, Yingqian Chai, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Construction and application of star polycation nanocarrier-based microRNA delivery system in Arabidopsis and maize
Yang Jia, Shuo Yan, Shipeng Xie, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 27
New insights for regulatory T cell in lupus nephritis
Yixi Li, Donge Tang, Lianghong Yin, et al.
Autoimmunity Reviews (2022) Vol. 21, Iss. 8, pp. 103134-103134
Closed Access | Times Cited: 26
Recent advances of nanotechnology application in autoimmune diseases – A bibliometric analysis
Rendong He, Li Li, Tingjun Zhang, et al.
Nano Today (2022) Vol. 48, pp. 101694-101694
Closed Access | Times Cited: 25
Antigen‐specific mRNA lipid nanoparticle platforms for the prevention and treatment of allergy and autoimmune diseases
Emma Y. Yim, Amanda C. Zhou, Yvonne C. Yim, et al.
BMEMat (2023) Vol. 2, Iss. 2
Open Access | Times Cited: 16
Exploring the theranostic potentials of miRNA and epigenetic networks in autoimmune diseases: A comprehensive review
Sagnik Nag, Oishi Mitra, G. Tripathi, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 12
Open Access | Times Cited: 16
Bio-responsive Au-miR-183 inhibitor enhances immunotherapy in hepatocellular carcinoma by inducing immunogenic cell death
Liang Yin, Yu Wei, Ya Liu, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 498-517
Open Access | Times Cited: 6
Immunological Involvement of MicroRNAs in the Key Events of Systemic Lupus Erythematosus
Mingxuan Chi, Kuai Ma, Yunlong Li, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 31
Overcoming AZD9291 Resistance and Metastasis of NSCLC via Ferroptosis and Multitarget Interference by Nanocatalytic Sensitizer Plus AHP‐DRI‐12
Liting Wang, Hao Fu, Liwei Song, et al.
Small (2022) Vol. 19, Iss. 4
Closed Access | Times Cited: 21
Biomaterial-enhanced treg cell immunotherapy: A promising approach for transplant medicine and autoimmune disease treatment
Kazem Mashayekhi, Khashayarsha Khazaie, William A. Faubion, et al.
Bioactive Materials (2024) Vol. 37, pp. 269-298
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top